Clinical Trials on Refractory Overactive Bladder

Total 6978 results

Velicept Therapeutics, Inc.

Completed

A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001) (VEL-2001)

Overactive Bladder

United States
R-Pharm
Synergy Research Inc.

Completed

Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder.

Overactive Bladder

Russian Federation
The Hospital of Vestfold
South-Eastern Norway Regional Health Authority

Completed

Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB)

Overactive Bladder

Norway
Mansoura University

Unknown

Delivery of Intravesical Botulinum Toxin A Using Low Energy Shock Waves in Treatment of Overactive Bladder: A Feasibility Study

Overactive Bladder | Botulinum Toxin | ESWL | Intravesical

Egypt
Sanofi

Completed

SSR240600C Treatment in Women With Overactive Bladder (BILADY)

Overactive Bladder

France, Germany, Netherlands, Portugal, Czech Republic, United States, Canada
Astellas Pharma Inc

Completed

Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease

Overactive Bladder | Cardiovascular Disease

Japan
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.

Overactive Bladder

France
Kissei Pharmaceutical Co., Ltd.

Completed

A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder

Overactive Bladder

Japan
Kissei Pharmaceutical Co., Ltd.

Withdrawn

Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

Overactive Bladder

Japan
Watson Pharmaceuticals

Completed

A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo

Overactive Bladder

United States
Imbrium Therapeutics
Purdue Pharma LP

Active, not recruiting

Study of V117957 in Overactive Bladder Syndrome

Overactive Bladder Syndrome

United States
Far Eastern Memorial Hospital
National Science Council, Taiwan

Completed

Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms.

Overactive Bladder Syndrome | Lower Urinary Tract Dysfunction

Taiwan
Ege University

Completed

Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder

Overactive Bladder | Overactive Bladder Syndrome

Turkey
Stony Brook University
Laborie Medical Technologies Inc.

Terminated

Condensed Percutaneous Tibial Nerve Stimulation (PTNS) Protocol

Overactive Bladder Syndrome

United States
Kasr El Aini Hospital

Unknown

Does Mirabegron Have a Positive Impact on Sexual Function in Females With Overactive Bladder

Females With Overactive Bladder Symptoms, Urgency & Urge Incontinence
Medstar Health Research Institute
University of Oklahoma; University of Texas; Indiana University

Completed

Sexual Function Trial of Overactive Bladder: Medication Versus PTNS (STOMP)

Overactive Bladder | Female Sexual Dysfunction

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy

Prostate Adenocarcinoma

United States
Pfizer

Completed

Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years

Overactive Bladder | Neurogenic Detrusor Overactivity

United States
Walter Reed National Military Medical Center

Recruiting

Xeomin vs Botox for Treatment of Overactive Bladder Syndrome

Overactive Bladder Syndrome

United States
William Beaumont Hospitals

Recruiting

BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder (EmsellaOAB)

Overactive Bladder | Overactive Bladder Syndrome | Urinary Urgency | Urinary Frequency

United States
Far Eastern Memorial Hospital

Recruiting

Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin

Overactive Bladder Syndrome

Taiwan
Taris Biomedical LLC

Completed

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

Idiopathic Overactive Bladder With Urinary Incontinence

United States
Pamukkale University

Completed

Pelvic Floor Magnetic Stimulation in Women With Idiopathic Overactive Bladder

Urge Incontinence Episodes After the Magnetic Stimulation Added to Bladder Training in Women With Idiopathic Overactive Bladder

Turkey
Ankara Training and Research Hospital

Completed

Overactive Bladder in Elderly Patients- An Early Warning of Coronary Artery Disease

Coronary Artery Disease | Overactive Bladder Syndrome

Turkey
Aristotle University Of Thessaloniki

Recruiting

Assessment of Potential Biomarkers in Women With Symptoms of Overactive Bladder and Pelvic Organ Prolapse

Overactive Bladder

Greece
Urovant Sciences GmbH

Completed

An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). (Empowur)

Overactive Bladder

United States
Biruni University

Completed

Training and Counseling Program for Overactive Bladder Treatment

Overactive Bladder
Women and Infants Hospital of Rhode Island

Completed

Audiovisual Stimulus During Urodynamics (AVUDE)

Overactive Bladder
Liverpool Women's NHS Foundation Trust
Manchester Metropolitan University

Completed

Use of Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) in Maintaining OAB Symptoms Improvement.

Overactive Bladder

United Kingdom
University of Pennsylvania
Pfizer

Completed

Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder (PfizerOABLUT)

Overactive Bladder

United States
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)

Overactive Bladder

Poland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
Allergan

Completed

Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Overactive Bladder

Canada, United States
Pfizer

Completed

A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder

Overactive Bladder

United States
Lee's Pharmaceutical Limited
APOGEPHA Arzneimittel GmbH

Completed

Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder

Overactive Bladder

China
Maastricht University Medical Center
Scientific Foundation Urology Maastricht

Completed

Screening Method in Sacral Neuromodulation

Overactive Bladder | Urinary Retention

Netherlands
Ludwig-Maximilians - University of Munich

Recruiting

Lower Urinary Tract Symptoms After Intravesical Therapy (LUTSI)

Overactive Bladder | Lower Urinary Tract Symptoms | Chemotherapy Effect | Chemotherapeutic Toxicity

Germany
Campbell Grant

Terminated

Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms

Overactive Bladder

United States
Urological Sciences Research Foundation
Allergan

Unknown

This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo. (BTX0621)

Overactive Bladder

United States
Bayer

Completed

Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB) (OVADER)

Overactive Bladder

Austria, Singapore, New Zealand, Australia, Portugal, Czechia, Poland, Germany, Sweden
Urovant Sciences GmbH

Completed

A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) (Empowur)

Overactive Bladder

United States, Latvia, Hungary, Canada, Lithuania, Poland
Velicept Therapeutics, Inc.

Completed

Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women

Overactive Bladder

United States
Merck Sharp & Dohme LLC

Completed

A Single Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Participants With Renal Insufficiency (MK-4618-014)

Overactive Bladder
Pfizer

Completed

This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive Bladder

Overactive Bladder
BlueWind Medical

Withdrawn

Overactive Bladder Posterior Tibial Implantable MIcro STimulator - 1 (OPTIMIST-1)

Overactive Bladder
University of Rochester

Completed

Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?

Overactive Bladder

United States
Universidad de Valparaiso
Recalcine (GynoPharm)

Completed

Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women

Overactive Bladder

Chile
NYU Langone Health

Terminated

Feasibility of "At-home" Titration of Solifenacin

Overactive Bladder
Asan Medical Center
Samsung Medical Center; Seoul National University Hospital; Cheil General Hospital... and other collaborators

Completed

Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin (OAB)

Overactive Bladder

Korea, Republic of
US Department of Veterans Affairs

Completed

Behavioral Treatment of Overactive Bladder in Men (MOTIVE)

Overactive Bladder

United States
Allergan

Completed

Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence

Overactive Bladder

Poland, United Kingdom, Belgium, Russian Federation, Czech Republic, Germany, United States

Clinical Trials on Refractory Overactive Bladder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations